Advertisement
News
Subscribe to MDT Magazine News

Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter

March 1, 2011 6:34 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., March 1, 2011 /- Perrigo (Nasdaq: PRGO;TASE) today announced that, as part of the anticipated follow-up to the warning letter Perrigo received on April 30, 2010, the Detroit Office of the Food and Drug Administration (FDA) has arrived at their Allegan facility for the...

TOPICS:

RXi raising $8.1M from public equities sale

March 1, 2011 4:37 am | by Mass High Tech: The Journal of New England Technology | Comments

RXi Pharmaceuticals Corp. of Worcester is raising $8.1 million through a public stock offering of 6 million units of combined stocks and warrants, with proceeds to be used for "general corporate purposes."

Quiet NeuroPhage nabs $12.4M in Series B round

March 1, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge-based NeuroPhage Pharmaceuticals Inc. has landed $12.4 million in a Series B round of funding led by MerieuxDeveloppement, the investment arm of French industrial holding company InstitutMerieux.

Advertisement

Volcano Corporation Announces Webcast of March 9th Analyst Day

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 1, 2011 /-Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, will hold its 2011 Analyst Day on Wednesday,...

TOPICS:

Former PayPal, Palantir Executive Jason Portnoy Joins Practice Fusion as CFO

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, March 1, 2011 /- Practice Fusion, the fastest growing Electronic Medical Record (EMR) community in the US, today announced Jason Portnoy as the company's Chief Financial Officer.  Practice Fusion delivers the leading, free, cloud-based EMR to physicians; enabling...

TOPICS:

BioMarin to Present at the Cowen Health Care Conference

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

NOVATO, Calif., March 1, 2011 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Dan Maher, Senior Vice President of Product Development of BioMarin, will present a company update at the Cowen Health Care Conference in Boston on Tuesday, March 8, 2011 at 8:00 a.m. ET....

TOPICS:

Veteran Executive Ron Wall Joins Advanstar Communications as Executive Vice President, Pharmaceutical/Science

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SANTA MONICA, Calif., March 1, 2011 /- Advanstar Communications, Inc., a leading worldwide media company providing integrated marketing solutions for the Fashion, Life Sciences and Powersports industries, announced today that it has appointed Ron Wall to fill its newly created position of...

TOPICS:

Merger of Four Pharmaceutical Companies Announced

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

COOKEVILLE, Tenn., March 1, 2011 /- Four successful contract packaging and re-packaging companies in the pharmaceutical industry recently joined forces to create a new, single-source industry leader called Aphena Pharma Solutions . Aphena is a new corporation based on a strategic alliance...

TOPICS:
Advertisement

Chimerix to Present at Cowen and Company 31st Annual Health Care Conference

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

DURHAM, N.C., March 1, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics to address life-threatening diseases, announced today that Kenneth I. Moch, President and Chief Executive Officer, will present at the Cowen and Company 31st Annual...

TOPICS:

Prometheus Highlights Record Performance in 2010

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 1, 2011 /- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today highlighted its financial results and product development progress for the year ended December 31, 2010. "Prometheus had another record year in 2010, our 14th consecutive...

TOPICS:

Nektar Therapeutics' President and CEO Howard W. Robin to Present at the 31st Annual Cowen and Company Healthcare Conference in Boston

March 1, 2011 4:36 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, March 1, 2011 /- Nektar Therapeutics' (Nasdaq: NKTR ) President and Chief Executive Officer, Howard W. Robin, is scheduled to present at the 31st Annual Cowen and Company Healthcare Conference at the Boston Marriott Copley Place on Tuesday, March 8, 2011 at 11:00 a.m....

TOPICS:

Heska Introduces New Lactate Meter Analyzer

March 1, 2011 4:35 am | by Bio-Medicine.Org | Comments

LOVELAND, Colo., March 1, 2011 /- Heska Corporation (Nasdaq: HSKA ; "Heska"), a leading provider of advanced diagnostic and specialty products to veterinarians, today announced the addition of a lactate meter analyzer to its portfolio of in-clinic blood analyzers. (Logo:  ...

TOPICS:

New Image Global, Inc. Partners With Limbs For U, Charitable Service Group to Provide Prosthetic Limbs in the Dominican Republic

March 1, 2011 4:35 am | by Bio-Medicine.Org | Comments

CORONA, Calif., March 1, 2011 /- New Image Global, Inc. is a California-based company located at 1672 Railroad Street in Corona, California.  The company owns and operates a socially conscious tobacco company manufacturing cigar wraps and cigarillos. New Image Global carries several...

TOPICS:

Wellbeing Company Helps People To A Healthier Life With New Advice Website

March 1, 2011 4:33 am | by RealWire | Comments

Better by Nature helps to tackle issues from Energy and Allergies to Stress, Detoxing and Weight Loss A new source of healthcare information and support has been launched aimed at providing expert advice on natural ways to manage a range of conditions. Created by Better by Nature founders...

TOPICS:

Ziopharm reports 4Q loss on costs

March 1, 2011 2:45 am | by The Associated Press | Comments

Biotechnology company Ziopharm Oncology Inc. on Tuesday reported a fourth-quarter loss on higher operating costs and a decline in the value of its warrants.The company reported a net loss of $11.9 million, or 25 cents per share, in the three months ended Dec 31. That compares with profit of...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading